Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference32 articles.
1. Treatment options for COVID-19: a review;Ali;Front Med,2020
2. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);Yao;Clin Infect Dis,2020
3. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic;Tripathy;Int J Antimicrob Agents,2020
4. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): a role for iron homeostasis?;Quiros Roldan;Pharmacol Res,2020
5. Healthcare workers & SARS-CoV-2 infection in India: a case-control investigation in the time of COVID-19;Chatterjee;Indian J Med Res,2020
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk factors of using late-autophagy inhibitors: Aspects to consider when combined with anticancer therapies;Biochemical Pharmacology;2024-07
2. Nanoparticles based on carbon dots and reduced graphene oxide as electrochemical sensor for voltammetric determination of hydroxychloroquine;Electroanalysis;2024-05-30
3. SARS-CoV-2 Nsp8 induces mitophagy by damaging mitochondria;Virologica Sinica;2023-08
4. Increase in veterinary prescriptions of azithromycin during the COVID-19 pandemic in Brazil;The Journal of Infection in Developing Countries;2023-07-27
5. A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics;Iranian Journal of Science;2023-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3